Analytical Chemistry,
Journal Year:
2021,
Volume and Issue:
93(8), P. 4126 - 4133
Published: Feb. 11, 2021
The
outbreak
of
the
pandemic
caused
by
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
calls
for
an
urgent
unmet
need
developing
a
facial
and
cost-effective
detection
method.
requirement
well-trained
personnel
sophisticated
instrument
current
primary
mean
(reverse
transcription
polymerase
chain
reaction,
RT-PCR)
may
hinder
practical
application
worldwide.
In
this
regard,
reverse
recombinase
amplification
(RT-RPA)
coupled
with
CRISPR-Cas12a
colorimetric
assay
is
proposed
SARS-CoV-2
detection.
methodology
we
have
described
herein
utilizes
DNA-modified
gold
nanoparticles
(AuNPs)
as
universal
readout
can
specifically
target
ORF1ab
N
regions
genome.
After
virus
genome
amplified
through
RT-RPA,
resulting
abundant
dsDNA
will
bind
activate
Cas12a.
Under
trans-cleavage
degradation,
capped
DNA
substrate
be
hydrolyzed
gradually
from
AuNPs,
demonstrating
change
in
surface
plasmon
resonance
(SPR),
which
facially
monitored
UV-vis
absorbance
spectroscopy
naked
eye
observation.
high
efficiency
RT-RPA
Cas12a
process
bring
sensitivity
our
method
to
1
copy
viral
sequence
per
test.
Notably,
under
dual
variations
inspecting
isothermal
activation
process,
false
positive
events
other
beta
coronavirus
members
effectively
avoided
thus
significantly
improve
specificity.
Furthermore,
reliability
validated
standard
clinical
samples
hospital
laboratory
department.
Through
integration
inherently
specificity
RPA-coupled
system
intrinsic
simplicity
AuNP-based
assay,
increases
testing
availability
SARS-CoV-2.
Advanced Materials,
Journal Year:
2019,
Volume and Issue:
31(30)
Published: May 15, 2019
Abstract
Disposable
sensors
are
low‐cost
and
easy‐to‐use
sensing
devices
intended
for
short‐term
or
rapid
single‐point
measurements.
The
growing
demand
fast,
accessible,
reliable
information
in
a
vastly
connected
world
makes
disposable
increasingly
important.
areas
of
application
such
numerous,
ranging
from
pharmaceutical,
agricultural,
environmental,
forensic,
food
sciences
to
wearables
clinical
diagnostics,
especially
resource‐limited
settings.
capabilities
can
extend
beyond
measuring
traditional
physical
quantities
(for
example,
temperature
pressure);
they
provide
critical
chemical
biological
(chemo‐
biosensors)
that
be
digitized
made
available
users
centralized/decentralized
facilities
data
storage,
remotely.
These
features
could
pave
the
way
new
classes
systems
health,
food,
environmental
monitoring
democratize
across
globe.
Here,
brief
insight
into
materials
basics
(methods
transduction,
molecular
recognition,
amplification)
is
provided
followed
by
comprehensive
overview
currently
used
medical
analysis.
Finally,
views
on
how
field
will
continue
its
evolution
discussed,
including
future
trends,
challenges,
opportunities.
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: Sept. 18, 2020
The
recent
outbreak
of
novel
coronavirus
(SARS-CoV-2)
causing
COVID-19
disease
spreads
rapidly
in
the
world.
Rapid
and
early
detection
SARS-CoV-2
facilitates
intervention
prevents
spread.
Here,
we
present
an
All-In-One
Dual
CRISPR-Cas12a
(AIOD-CRISPR)
assay
for
one-pot,
ultrasensitive,
visual
detection.
By
targeting
SARS-CoV-2's
nucleoprotein
gene,
two
CRISPR
RNAs
without
protospacer
adjacent
motif
(PAM)
site
limitation
are
introduced
to
develop
AIOD-CRISPR
detect
nucleic
acids
with
a
sensitivity
few
copies.
We
validate
by
using
clinical
swab
samples
obtain
consistent
results
RT-PCR
assay.
Furthermore,
low-cost
hand
warmer
(~$0.3)
is
used
as
incubator
within
20
min,
enabling
instrument-free,
at
point
care.
Thus,
our
method
has
significant
potential
provide
rapid,
sensitive,
one-pot
point-of-care
SARS-CoV-2.
Advanced Science,
Journal Year:
2021,
Volume and Issue:
8(15)
Published: June 10, 2021
Abstract
Cytokines
are
critical
mediators
that
oversee
and
regulate
immune
inflammatory
responses
via
complex
networks
serve
as
biomarkers
for
many
diseases.
Quantification
of
cytokines
has
significant
value
in
both
clinical
medicine
biology
the
levels
provide
insights
into
physiological
pathological
processes
can
be
used
to
aid
diagnosis
treatment.
their
significance
introduced
from
perspective
pro‐
anti‐inflammatory
effects.
Factors
affecting
quantification
biological
fluids,
native
different
body
sample
processing
storage
conditions,
sensitivity
freeze‐thaw,
soluble
cytokine
receptors
discussed.
In
addition,
recent
advances
vitro
vivo
assays,
biosensors
based
on
signal
outputs
intracellular
extracellular
protein
expression
summarized.
Various
platforms
high‐sensitivity
reliable
measurement
scenarios
discussed,
commercially
available
assays
compared.
A
discussion
challenges
development
advancement
technologies
aim
achieve
real‐time
multiplex
analysis
point‐of‐care
situations
applicable
biomedical
research
practice
Angewandte Chemie International Edition,
Journal Year:
2019,
Volume and Issue:
58(48), P. 17399 - 17405
Published: Oct. 1, 2019
An
accurate,
rapid,
and
cost-effective
biosensor
for
the
quantification
of
disease
biomarkers
is
vital
development
early-diagnostic
point-of-care
systems.
The
recent
discovery
trans-cleavage
property
CRISPR
type
V
effectors
makes
a
potential
high-accuracy
bio-recognition
tool.
Herein,
CRISPR-Cas12a
(cpf1)
based
electrochemical
(E-CRISPR)
reported,
which
more
portable
than
optical-transduction-based
biosensors.
Through
optimizing
in
vitro
activity
Cas12a,
E-CRIPSR
was
used
to
detect
viral
nucleic
acids,
including
human
papillomavirus
16
(HPV-16)
parvovirus
B19
(PB-19),
with
picomolar
sensitivity.
aptamer-based
E-CRISPR
cascade
further
designed
detection
transforming
growth
factor
β1
(TGF-β1)
protein
clinical
samples.
As
demonstrated,
could
enable
portable,
diagnostic
ACS Nano,
Journal Year:
2021,
Volume and Issue:
15(3), P. 3593 - 3611
Published: Feb. 19, 2021
Lateral
flow
assays
(LFAs)
are
paper-based
point-of-care
(POC)
diagnostic
tools
that
widely
used
because
of
their
low
cost,
ease
use,
and
rapid
format.
Unfortunately,
traditional
commercial
LFAs
have
significantly
poorer
sensitivities
(μM)
specificities
than
standard
laboratory
tests
(enzyme-linked
immunosorbent
assay,
ELISA:
pM-fM;
polymerase
chain
reaction,
PCR:
aM),
thus
limiting
impact
in
disease
control.
In
this
Perspective,
we
review
the
evolving
efforts
to
increase
sensitivity
specificity
LFAs.
Recent
work
improve
through
assay
improvement
includes
optimization
kinetics
signal
amplification
by
either
reader
systems
or
additional
reagents.
Together,
these
produced
with
ELISA-level
(pM-fM).
addition,
sample
preamplification
can
be
applied
both
nucleic
acids
(direct
amplification)
other
analytes
(indirect
prior
LFA
testing,
which
lead
PCR-level
(aM)
sensitivity.
However,
strategies
also
detection
time
complexity,
inhibits
large-scale
POC
use
Perspectives
achieve
future
(<30
min),
ultrasensitive
(PCR-level),
"sample-to-answer"
diagnostics
provided.
case
specificity,
recent
research
focused
on
high-affinity
molecules
reduce
nonspecific
binding.
Furthermore,
novel
highly
specific
molecules,
such
as
CRISPR/Cas
systems,
integrated
into
diagnosis
produce
not
only
but
diagnostics.
summary,
continuing
improvements,
may
soon
offer
performance
at
is
competitive
techniques
while
retaining
a
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: March 9, 2020
Abstract
Multiplexed
CRISPR
technologies,
in
which
numerous
gRNAs
or
Cas
enzymes
are
expressed
at
once,
have
facilitated
powerful
biological
engineering
applications,
vastly
enhancing
the
scope
and
efficiencies
of
genetic
editing
transcriptional
regulation.
In
this
review,
we
discuss
multiplexed
technologies
describe
methods
for
assembly,
expression
processing
synthetic
guide
RNA
arrays
vivo.
Applications
that
benefit
from
including
cellular
recorders,
circuits,
biosensors,
combinatorial
perturbations,
large-scale
genome
rewiring
metabolic
pathways,
highlighted.
We
also
offer
a
glimpse
emerging
challenges
emphasize
experimental
considerations
future
studies.
Advanced Materials,
Journal Year:
2019,
Volume and Issue:
31(51)
Published: Oct. 30, 2019
Abstract
Noncoding
small
RNAs,
such
as
microRNAs,
are
becoming
the
biomarkers
of
choice
for
multiple
diseases
in
clinical
diagnostics.
A
dysregulation
these
microRNAs
can
be
associated
with
many
different
diseases,
cancer,
dementia,
and
cardiovascular
conditions.
The
key
effective
treatment
is
an
accurate
initial
diagnosis
at
early
stage,
improving
patient's
survival
chances.
In
this
work,
first
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)/Cas13a‐powered
microfluidic,
integrated
electrochemical
biosensor
on‐site
detection
introduced.
Through
unique
combination,
quantification
potential
tumor
markers
microRNA
miR‐19b
miR‐20a
realized
without
any
nucleic
acid
amplification.
With
a
readout
time
9
min
overall
process
less
than
4
h,
limit
10
p
m
achieved,
using
measuring
volume
0.6
µL.
Furthermore,
feasibility
platform
to
detect
serum
samples
children,
suffering
from
brain
demonstrated.
validation
obtained
results
standard
quantitative
real‐time
polymerase
chain
reaction
method
shows
ability
CRISPR‐powered
system
low‐cost,
easily
scalable,
target
amplification‐free
tool
based
Analytical Chemistry,
Journal Year:
2019,
Volume and Issue:
91(19), P. 12156 - 12161
Published: Aug. 28, 2019
A
rapid
and
sensitive
method
is
crucial
for
nucleic
acid
detection.
Recently,
RNA-guided
CRISPR/Cas12a
nuclease-based
methods
present
great
promise
In
the
methods,
however,
DNA
amplification
subsequent
Cas12a
cleavage
separated
whole
process
takes
as
long
2
h.
Most
importantly,
uncapping
operation
increases
risk
of
aerosol
contamination.
this
study,
we
propose
a
CRISPR/Cas12a-based
named
"Cas12aVDet"
By
integrating
recombinase
polymerase
(RPA)
with
in
single
reaction
system,
detection
can
be
accomplished
30
min
contamination
avoided.
The
signal
observed
by
naked
eye
under
blue
light.
This
could
detect
at
molecule
level
demonstrated
100%
accuracy
mycoplasma
detection,
presenting
potential
variety
applications.